DK0983058T3 - Medicinske aerosolprodukter - Google Patents

Medicinske aerosolprodukter

Info

Publication number
DK0983058T3
DK0983058T3 DK98922409T DK98922409T DK0983058T3 DK 0983058 T3 DK0983058 T3 DK 0983058T3 DK 98922409 T DK98922409 T DK 98922409T DK 98922409 T DK98922409 T DK 98922409T DK 0983058 T3 DK0983058 T3 DK 0983058T3
Authority
DK
Denmark
Prior art keywords
ciclesonide
butyl
formulations
aerosol products
medical aerosol
Prior art date
Application number
DK98922409T
Other languages
Danish (da)
English (en)
Inventor
Martin J Oliver
Kanu M Fatania
John S Scott
Helgert Muller
Original Assignee
Altana Pharma Ag
Minnesota Mining & Mfg
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GBGB9710496.2A external-priority patent/GB9710496D0/en
Priority claimed from GBGB9803990.2A external-priority patent/GB9803990D0/en
Application filed by Altana Pharma Ag, Minnesota Mining & Mfg filed Critical Altana Pharma Ag
Application granted granted Critical
Publication of DK0983058T3 publication Critical patent/DK0983058T3/da

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/10Dispersions; Emulsions
    • A61K9/12Aerosols; Foams
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/007Pulmonary tract; Aromatherapy
    • A61K9/0073Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A61K9/008Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy comprising drug dissolved or suspended in liquid propellant for inhalation via a pressurized metered dose inhaler [MDI]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/56Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/58Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/10Dispersions; Emulsions
    • A61K9/12Aerosols; Foams
    • A61K9/124Aerosols; Foams characterised by the propellant
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • A61P11/06Antiasthmatics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M15/00Inhalators
    • A61M15/009Inhalators using medicine packages with incorporated spraying means, e.g. aerosol cans

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Dispersion Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pulmonology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Otolaryngology (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Containers And Packaging Bodies Having A Special Means To Remove Contents (AREA)
  • Materials For Medical Uses (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Thermotherapy And Cooling Therapy Devices (AREA)
  • Steroid Compounds (AREA)
DK98922409T 1997-05-21 1998-05-18 Medicinske aerosolprodukter DK0983058T3 (da)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GBGB9710496.2A GB9710496D0 (en) 1997-05-21 1997-05-21 Medicinal aerosol products
GBGB9803990.2A GB9803990D0 (en) 1998-02-25 1998-02-25 Medicinal aerosol products
PCT/US1998/010155 WO1998052542A1 (en) 1997-05-21 1998-05-18 Medicinal aerosol products

Publications (1)

Publication Number Publication Date
DK0983058T3 true DK0983058T3 (da) 2003-11-24

Family

ID=26311564

Family Applications (1)

Application Number Title Priority Date Filing Date
DK98922409T DK0983058T3 (da) 1997-05-21 1998-05-18 Medicinske aerosolprodukter

Country Status (28)

Country Link
US (1) US6120752A (pt)
EP (1) EP0983058B1 (pt)
JP (4) JP2001526685A (pt)
KR (1) KR100527643B1 (pt)
CN (1) CN1149073C (pt)
AT (1) ATE245966T1 (pt)
AU (1) AU726835B2 (pt)
BG (1) BG64268B1 (pt)
BR (1) BR9809448A (pt)
CA (1) CA2290521C (pt)
CZ (1) CZ298253B6 (pt)
DE (1) DE69816811T2 (pt)
DK (1) DK0983058T3 (pt)
EA (1) EA002381B1 (pt)
ES (1) ES2205491T3 (pt)
HK (1) HK1027027A1 (pt)
HU (1) HU226694B1 (pt)
IL (1) IL132738A (pt)
ME (1) ME01631B (pt)
NO (2) NO327716B1 (pt)
NZ (1) NZ500874A (pt)
PL (1) PL191523B1 (pt)
PT (1) PT983058E (pt)
RS (1) RS49628B (pt)
SK (1) SK283930B6 (pt)
TR (1) TR199902863T2 (pt)
UA (1) UA58551C2 (pt)
WO (1) WO1998052542A1 (pt)

Families Citing this family (32)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7101534B1 (en) 1991-12-18 2006-09-05 3M Innovative Properties Company Suspension aerosol formulations
US6315985B1 (en) 1999-06-18 2001-11-13 3M Innovative Properties Company C-17/21 OH 20-ketosteroid solution aerosol products with enhanced chemical stability
AR026072A1 (es) * 1999-10-20 2002-12-26 Nycomed Gmbh Composicion farmaceutica que contiene ciclesonida para aplicacion a la mucosa
AR026073A1 (es) * 1999-10-20 2002-12-26 Nycomed Gmbh Composicion farmaceutica acuosa que contiene ciclesonida
GB0002798D0 (en) * 2000-02-09 2000-03-29 Glaxo Group Ltd Actuator nozzle for metered dose inhaler
GB0208742D0 (en) 2002-04-17 2002-05-29 Bradford Particle Design Ltd Particulate materials
GB0207899D0 (en) * 2002-04-05 2002-05-15 3M Innovative Properties Co Formoterol and cielesonide aerosol formulations
WO2004033478A2 (en) * 2002-10-08 2004-04-22 Sepracor Inc. Fatty acid modified forms of glucocorticoids and their use as anti-inflammatory
ES2728672T3 (es) * 2002-10-25 2019-10-28 Honeywell Int Inc Composiciones que contienen olefinas sustituidas con flúor
JP4755495B2 (ja) * 2002-12-12 2011-08-24 ニコメッド ゲゼルシャフト ミット ベシュレンクテル ハフツング 組合せ医薬品
MY143936A (en) * 2003-03-27 2011-07-29 Nycomed Gmbh Process for preparing crystalline ciclesonide with defined particle size
AU2004241746A1 (en) * 2003-05-22 2004-12-02 Nycomed Gmbh Salmeterol and ciclesonide combination
EP1635845A1 (en) * 2003-06-13 2006-03-22 ALTANA Pharma AG Formoterol and ciclesonide combination
WO2005025578A1 (en) * 2003-09-16 2005-03-24 Altana Pharma Ag Use of ciclesonide for the treatment of respiratory diseases
GB2406283B (en) 2003-09-24 2006-04-05 Altana Pharma Ag Compliance monitor and method
US9308199B2 (en) 2004-04-29 2016-04-12 Honeywell International Inc. Medicament formulations
AR041873A1 (es) * 2003-10-30 2005-06-01 Pablo Cassara Srl Lab Una formulacion farmaceutica en aerosol adecuada para la inhalacion oral o nasal que contienen glucocorticoides en solucion estable al almacenamiento; un metodo para estabilzar formulaciones y uso de un agente estabilizante
PE20050941A1 (es) 2003-12-16 2005-11-08 Nycomed Gmbh Suspensiones acuosas de ciclesonida para nebulizacion
WO2005065185A2 (en) * 2003-12-24 2005-07-21 Collegium Pharmaceuticals, Inc. Temperature-stable formulations, and methods of development thereof
WO2005102354A1 (en) * 2004-04-20 2005-11-03 Altana Pharma Ag Use of ciclesonide for the treatment of respiratory diseases in a smoking patient
EP1796679A1 (en) * 2004-09-10 2007-06-20 Altana Pharma AG Ciclesonide and syk inhibitor combination and methods of use thereof
CN103462894A (zh) * 2005-03-16 2013-12-25 霍尼韦尔国际公司 药物递送制剂、装置和方法
WO2007068007A1 (en) * 2005-12-07 2007-06-14 Harm Benjamin Steyn Use of a disinfectant for treating respiratory tract infections
JP5825757B2 (ja) 2007-02-11 2015-12-02 マップ・ファーマシューティカルズ・インコーポレイテッド 副作用プロファイルを最小限にしながら片頭痛の迅速な緩和を可能にするdheの治療上の投与方法
US20100120737A1 (en) * 2008-11-10 2010-05-13 Martin Feth Amorphous ciclesonide
US8765696B2 (en) * 2009-03-09 2014-07-01 Mikasa Seiyaku Co., Ltd. Steroid compound
WO2011135585A2 (en) 2010-04-28 2011-11-03 Cadila Healthcare Limited Aqueous pharmaceutical solution of ciclesonide
RU2642624C2 (ru) * 2010-10-12 2018-01-25 Сипла Лимитед Фармацевтическая композиция
WO2013024070A1 (en) 2011-08-18 2013-02-21 Nycomed Gmbh Pharmaceutical aerosol product for administration by oral or nasal inhalation
CN102335132A (zh) * 2011-10-12 2012-02-01 中山大学 一种细辛脑吸入气雾剂及其制备方法
WO2013114371A1 (en) 2012-02-01 2013-08-08 Protalix Ltd. Dry powder formulations of dnase i
US20170304459A1 (en) 2014-10-10 2017-10-26 Alnylam Pharmaceuticals, Inc. Methods and compositions for inhalation delivery of conjugated oligonucleotide

Family Cites Families (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2077229B (en) * 1980-05-16 1983-08-03 Neotechnic Eng Ltd Valve assembly for a pressurized aerosoldispensing container
GB8824804D0 (en) * 1988-10-22 1988-11-30 Fisons Plc Device
GB8828477D0 (en) * 1988-12-06 1989-01-05 Riker Laboratories Inc Medical aerosol formulations
US5225183A (en) * 1988-12-06 1993-07-06 Riker Laboratories, Inc. Medicinal aerosol formulations
GB8900267D0 (en) * 1989-01-06 1989-03-08 Riker Laboratories Inc Narcotic analgesic formulations and apparatus containing same
GB8921222D0 (en) * 1989-09-20 1989-11-08 Riker Laboratories Inc Medicinal aerosol formulations
IE67185B1 (en) * 1990-02-02 1996-03-06 Fisons Plc Propellant compositions
DE4003272A1 (de) * 1990-02-03 1991-08-08 Boehringer Ingelheim Kg Neue treibgasmischungen und ihre verwendung in arzneimittelzubereitungen
AU654813B2 (en) * 1990-03-23 1994-11-24 Minnesota Mining And Manufacturing Company The use of soluble fluorosurfactants for the preparation of metered-dose aerosol formulations
GR1001529B (el) * 1990-09-07 1994-03-31 Elmuquimica Farm Sl Μέ?οδος για την λήψη νέων 21-εστέρων της 16-17-ακετάλης της πρ να-1,4-διενο-3,20-διόνης.
JP2769925B2 (ja) * 1990-10-18 1998-06-25 ミネソタ マイニング アンド マニュファクチャリング カンパニー ベクロメタゾン17,21ジプロピオネートを含んで成るエアロゾル製剤
IL104068A (en) * 1991-12-12 1998-10-30 Glaxo Group Ltd Pharmaceutical preparations in a spray without surfactant containing 1, 1, 1, 2 tetrafluoroethane or 1,1,2,3,3 petafluor N propane as propellant
US5653962A (en) * 1991-12-12 1997-08-05 Glaxo Group Limited Aerosol formulations containing P134a and particulate medicaments
US5474758A (en) * 1993-07-28 1995-12-12 Minnesota Mining And Manufacturing Company Seals for use in an aerosol delivery device
NZ276637A (en) * 1993-12-20 1997-07-27 Minnesota Mining & Mfg Aerosol containing flunisolide, ethanol, and tetrafluoroethane and/or heptafluoropropane propellant
DE19541689A1 (de) * 1994-11-14 1996-05-15 Byk Gulden Lomberg Chem Fab Kombinationsarzneimittel
US5653961A (en) * 1995-03-31 1997-08-05 Minnesota Mining And Manufacturing Company Butixocort aerosol formulations in hydrofluorocarbon propellant
EE03997B1 (et) * 1995-04-14 2003-04-15 Glaxo Wellcome Inc. Albuterooli doseeriv inhalaator
HUP9800641A3 (en) * 1995-04-14 2001-04-28 Glaxo Wellcome Inc Res Triangl Metered dose inhaler for beclomethasone dipropionate
ES2206572T3 (es) * 1995-04-14 2004-05-16 Smithkline Beecham Corporation Inhalador de dosis medida para salmeterol.

Also Published As

Publication number Publication date
IL132738A0 (en) 2001-03-19
IL132738A (en) 2004-06-20
JP2011102301A (ja) 2011-05-26
SK283930B6 (sk) 2004-05-04
EP0983058A1 (en) 2000-03-08
PL191523B1 (pl) 2006-06-30
JP6178459B2 (ja) 2017-08-09
JP2015024999A (ja) 2015-02-05
NZ500874A (en) 2001-09-28
HU226694B1 (en) 2009-06-29
JP2016169222A (ja) 2016-09-23
AU726835B2 (en) 2000-11-23
NO995667D0 (no) 1999-11-18
PT983058E (pt) 2003-12-31
US6120752A (en) 2000-09-19
CZ298253B6 (cs) 2007-08-08
ATE245966T1 (de) 2003-08-15
DE69816811T2 (de) 2004-04-15
NO2009024I2 (no) 2010-08-16
EA002381B1 (ru) 2002-04-25
KR20010012810A (ko) 2001-02-26
CA2290521C (en) 2006-10-10
CA2290521A1 (en) 1998-11-26
WO1998052542A1 (en) 1998-11-26
CN1257421A (zh) 2000-06-21
CZ412499A3 (cs) 2000-02-16
SK157699A3 (en) 2000-05-16
CN1149073C (zh) 2004-05-12
RS49628B (sr) 2007-08-03
JP6087882B2 (ja) 2017-03-01
BG103902A (en) 2000-05-31
BG64268B1 (bg) 2004-08-31
HUP0002691A2 (hu) 2001-02-28
JP2001526685A (ja) 2001-12-18
EP0983058B1 (en) 2003-07-30
NO995667L (no) 1999-11-18
UA58551C2 (uk) 2003-08-15
DE69816811D1 (de) 2003-09-04
PL336885A1 (en) 2000-07-17
BR9809448A (pt) 2000-06-20
HUP0002691A3 (en) 2001-04-28
YU59899A (sh) 2002-06-19
NO2009024I1 (no) 2009-10-26
EA199900991A1 (ru) 2000-08-28
TR199902863T2 (xx) 2000-05-22
HK1027027A1 (en) 2001-01-05
ME01631B (me) 2007-08-03
ES2205491T3 (es) 2004-05-01
KR100527643B1 (ko) 2005-11-15
AU7496298A (en) 1998-12-11
NO327716B1 (no) 2009-09-14

Similar Documents

Publication Publication Date Title
DK0983058T3 (da) Medicinske aerosolprodukter
DE60126599D1 (de) Cannabis enthaltende pharmazeutische zusammensetzungen
HUP0303084A2 (hu) Gyulladásgátló hatású 17béta-karbotioát-17alfa-arilkarboniloxiloxi androsztán-származékok, eljárás az előállításukra, alkalmazásuk és ezeket tartalmazó gyógyszerkészítmények
HUP0102102A2 (hu) Pirazolinszármazékok, eljárás előállításukra, ezeket tartalmazó gyógyszerkészítmények és alkalmazásuk
DE60322200D1 (de) Formoterol und ciclesonid aerosol-formulierungen
DE60123793D1 (de) Neue aerosolformulierungen ein polares fluoriniertes molekül enthaltend
CL2004001325A1 (es) Una composicion farmaceutica de aerosol que comprende cilesonida solubilizada en un propelente hidrofluorocarbono y un co-solvente, de preferencia etanol, util como antiinflamatorio de las vias aereas.
HUP9900849A2 (hu) Eljárás danazol által kiváltott csonttömegvesztés minimalizálására alkalmas gyógyszerkészítmények előállítása
HUP0001773A2 (hu) Szubsztituált tetrahidropiridinszármazékok, eljárás előállításukra, továbbá a vegyületeket tartalmazó gyógyászati készítmények
HUP0004701A2 (hu) Új dezloratadin sók, az ezeket tartalmazó gyógyászati készítmények és eljárás azok előállítására
HUP0302070A2 (hu) Ritonavirt vagy egyéb HIV-proteáz gátló vegyületet tartalmazó gyógyszerkészítmények
JPS63264522A (ja) 消炎鎮痛剤用エアゾ−ル組成物
TH28989B (th) เททราไซคลิค ไทรเทอร์ปีน